Pages that link to "Q38200071"
Jump to navigation
Jump to search
The following pages link to Antibody-drug conjugates: an emerging concept in cancer therapy (Q38200071):
Displaying 50 items.
- Linkers Having a Crucial Role in Antibody-Drug Conjugates (Q26752763) (← links)
- Methods to Design and Synthesize Antibody-Drug Conjugates (ADCs) (Q26768654) (← links)
- Capturing Biological Activity in Natural Product Fragments by Chemical Synthesis (Q26772873) (← links)
- Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine's Tool Box (Q26782784) (← links)
- Enzymatic prenylation and oxime ligation for the synthesis of stable and homogeneous protein-drug conjugates for targeted therapy (Q27701980) (← links)
- Targeted Delivery of Proteasome Inhibitors to Somatostatin-Receptor-Expressing Cancer Cells by Octreotide Conjugation (Q27702302) (← links)
- Advances in Antibody Design (Q28817608) (← links)
- Strain Prioritization and Genome Mining for Enediyne Natural Products (Q28818668) (← links)
- Chemical Structure and Concentration of Intratumor Catabolites Determine Efficacy of Antibody Drug Conjugates (Q28828981) (← links)
- Current Status: Site-Specific Antibody Drug Conjugates (Q28829290) (← links)
- Bioconjugation of therapeutic proteins and enzymes using the expanded set of genetically encoded amino acids (Q30279245) (← links)
- In Vivo Activation of Duocarmycin-Antibody Conjugates by Near-Infrared Light (Q33612435) (← links)
- Synthesis and Cytotoxicity Evaluation of C4- and C5-Modified Analogues of the α,β-Unsaturated Lactone of Pironetin (Q33628649) (← links)
- State-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicines (Q34045119) (← links)
- Solid-phase bioconjugation of heterobifunctional adaptors for versatile assembly of bispecific targeting ligands (Q34074743) (← links)
- Improving the serum stability of site-specific antibody conjugates with sulfone linkers (Q34074771) (← links)
- Synthetic aptamer-polymer hybrid constructs for programmed drug delivery into specific target cells (Q34408096) (← links)
- Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicine (Q34698624) (← links)
- Site-specific antibody-drug conjugates: the nexus of bioorthogonal chemistry, protein engineering, and drug development (Q35105725) (← links)
- Cancer stratification by molecular imaging (Q35380664) (← links)
- Methods to Make Homogenous Antibody Drug Conjugates (Q35523479) (← links)
- Cargo-delivery platforms for targeted delivery of inhibitor cargos against botulism (Q35542237) (← links)
- Enzymatic functionalization of a nanobody using protein insertion technology (Q35597176) (← links)
- Translocation of Non-Canonical Polypeptides into Cells Using Protective Antigen (Q35856399) (← links)
- Microscale screening of antibody libraries as maytansinoid antibody-drug conjugates (Q35890716) (← links)
- A platform for constructing, evaluating, and screening bioconjugates on the yeast surface (Q36102147) (← links)
- Intracellular GSH-activated galactoside photosensitizers for targeted photodynamic therapy and chemotherapy. (Q36220307) (← links)
- Selective targeted delivery of doxorubicin via conjugating to anti-CD24 antibody results in enhanced antitumor potency for hepatocellular carcinoma both in vitro and in vivo (Q36378949) (← links)
- Near-IR Light-Mediated Cleavage of Antibody-Drug Conjugates Using Cyanine Photocages (Q36551221) (← links)
- Synthetically Modified Viral Capsids as Versatile Carriers for Use in Antibody-Based Cell Targeting. (Q36592213) (← links)
- Organometallic palladium reagents for cysteine bioconjugation (Q36733631) (← links)
- A "methyl extension" strategy for polyketide natural product linker site validation and its application to dictyostatin (Q36738065) (← links)
- Super enhanced permeability and retention (SUPR) effects in tumors following near infrared photoimmunotherapy (Q36777569) (← links)
- Antibody Therapeutics in Oncology (Q36791878) (← links)
- Site-Specific Dual Antibody Conjugation via Engineered Cysteine and Selenocysteine Residues. (Q36820693) (← links)
- Serum Stability and Affinity Optimization of an M2 Macrophage-Targeting Peptide (M2pep). (Q37048637) (← links)
- Field Guide to Challenges and Opportunities in Antibody-Drug Conjugates for Chemists. (Q37066113) (← links)
- Photonanomedicine: a convergence of photodynamic therapy and nanotechnology. (Q37115994) (← links)
- Discovery and characterization of hydroxylysine in recombinant monoclonal antibodies (Q37138489) (← links)
- Stoichiometric and irreversible cysteine-selective protein modification using carbonylacrylic reagents (Q37393159) (← links)
- Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, Potentiates the Activity of Standard of Care Therapeutics in Ovarian Cancer Models (Q37447340) (← links)
- Thermoresponsive Collagen/Cell Penetrating Hybrid Peptide as Nanocarrier in Targeting-Free Cell Selection and Uptake (Q37525095) (← links)
- Acetazolamide Serves as Selective Delivery Vehicle for Dipeptide-Linked Drugs to Renal Cell Carcinoma (Q37586387) (← links)
- Different tissue distribution properties for glycosylation variants of fusion proteins containing the p40 subunit of murine interleukin-12. (Q37559740) (← links)
- From Anthramycin to Pyrrolobenzodiazepine (PBD)-Containing Antibody-Drug Conjugates (ADCs). (Q37561359) (← links)
- Linker stability influences the anti-tumor activity of acetazolamide-drug conjugates for the therapy of renal cell carcinoma (Q37606966) (← links)
- Micro- and nanotechnologies for intracellular delivery (Q38244304) (← links)
- Natural product and natural product derived drugs in clinical trials. (Q38247457) (← links)
- Formylglycine, a post-translationally generated residue with unique catalytic capabilities and biotechnology applications. (Q38290367) (← links)
- Principles in the design of ligand-targeted cancer therapeutics and imaging agents. (Q38362491) (← links)